GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Central Pharmaceuticals Ltd (DHA:CENTRALPHL) » Definitions » Net Margin %

Central Pharmaceuticals (DHA:CENTRALPHL) Net Margin % : -145.40% (As of Sep. 2022)


View and export this data going back to 2013. Start your Free Trial

What is Central Pharmaceuticals Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Central Pharmaceuticals's Net Income for the three months ended in Sep. 2022 was BDT-9.08 Mil. Central Pharmaceuticals's Revenue for the three months ended in Sep. 2022 was BDT6.25 Mil. Therefore, Central Pharmaceuticals's net margin for the quarter that ended in Sep. 2022 was -145.40%.

The historical rank and industry rank for Central Pharmaceuticals's Net Margin % or its related term are showing as below:

DHA:CENTRALPHL' s Net Margin % Range Over the Past 10 Years
Min: -790.2   Med: 18.82   Max: 23.94
Current: -269.82


DHA:CENTRALPHL's Net Margin % is ranked worse than
90.6% of 1021 companies
in the Drug Manufacturers industry
Industry Median: 3.76 vs DHA:CENTRALPHL: -269.82

Central Pharmaceuticals Net Margin % Historical Data

The historical data trend for Central Pharmaceuticals's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Central Pharmaceuticals Net Margin % Chart

Central Pharmaceuticals Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.57 -790.20 -5.72 -262.51 -149.88

Central Pharmaceuticals Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Jun19 Sep19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Jun23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -173.11 -125.92 -856.07 -145.40 -

Competitive Comparison of Central Pharmaceuticals's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Central Pharmaceuticals's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Central Pharmaceuticals's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Central Pharmaceuticals's Net Margin % distribution charts can be found below:

* The bar in red indicates where Central Pharmaceuticals's Net Margin % falls into.



Central Pharmaceuticals Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Central Pharmaceuticals's Net Margin for the fiscal year that ended in Jun. 2023 is calculated as

Net Margin=Net Income (A: Jun. 2023 )/Revenue (A: Jun. 2023 )
=-43.957/29.329
=-149.88 %

Central Pharmaceuticals's Net Margin for the quarter that ended in Sep. 2022 is calculated as

Net Margin=Net Income (Q: Sep. 2022 )/Revenue (Q: Sep. 2022 )
=-9.083/6.247
=-145.40 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Central Pharmaceuticals  (DHA:CENTRALPHL) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Central Pharmaceuticals Net Margin % Related Terms

Thank you for viewing the detailed overview of Central Pharmaceuticals's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Central Pharmaceuticals (DHA:CENTRALPHL) Business Description

Traded in Other Exchanges
N/A
Address
South West Darus Salam Road, 2-A/1, 2nd Floor, Mirpur - 1, Dhaka, BGD, 1216
Central Pharmaceuticals Ltd is engaged in the manufacturing and marketing of medicines in Bangladesh. The company manufactures finished formulation products for general people, hospitals, clinics, government organizations, corporations, and other non-government organizations. Its product portfolio encompasses therapeutic categories including gastrointestinal, anti-infective, vitamins and minerals, allergy cough and cold, analgesic and musculoskeletal, dermatological, oral rehydration salt, and others. The products are in the dosage forms of tablets, capsules, liquid, and ointments.

Central Pharmaceuticals (DHA:CENTRALPHL) Headlines

No Headlines